Direct healthcare professional communication on serious hypersensitivity including anaphylaxis and angioedema

Hdl Handle:
http://hdl.handle.net/10147/97718
Title:
Direct healthcare professional communication on serious hypersensitivity including anaphylaxis and angioedema
Authors:
Amgen Inc.
Publisher:
Irish Medicines Board (IMB)
Issue Date:
16-Apr-2010
URI:
http://hdl.handle.net/10147/97718
Item Type:
Other
Language:
en
Keywords:
DRUG; REGULATION

Full metadata record

DC FieldValue Language
dc.contributor.authorAmgen Inc.en
dc.date.accessioned2010-04-30T09:44:17Z-
dc.date.available2010-04-30T09:44:17Z-
dc.date.issued2010-04-16-
dc.identifier.urihttp://hdl.handle.net/10147/97718-
dc.language.isoenen
dc.publisherIrish Medicines Board (IMB)en
dc.subjectDRUGen
dc.subjectREGULATIONen
dc.titleDirect healthcare professional communication on serious hypersensitivity including anaphylaxis and angioedemaen
dc.typeOtheren
All Items in Lenus, The Irish Health Repository are protected by copyright, with all rights reserved, unless otherwise indicated.